Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of <i>Enterobacteriaceae</i> and Enterococci-Reference-Cited by-同舟云学术

Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci

Published:2023-03-23 Issue:3 Volume:61 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Blanchard Laurine S.¹^ORCID,Armstrong Thomas P.²,Kresken Michael³,Emery Christopher L.⁴,Ying Yun X.⁵,Sauvonnet Véronique⁶,Zambardi Gilles⁶

Affiliation:

1. bioMérieux, SA, Marcy l’Etoile, France

2. bioMérieux Inc., Hazelwood, Missouri, USA

3. Antiinfectives Intelligence, GmbH, Cologne, Germany

4. Indiana University School of Medicine, Indianapolis, Indiana, USA

5. Quest Diagnostics, Lewisville, Texas, USA

6. bioMérieux, SA, La Balme-les-Grottes, France

Abstract

Eravacycline (ERV) (brand name Xerava [Tetraphase]) is a new tetracycline-class antibacterial that has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for treatment of complicated intra-abdominal infections (cIAIs).

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.01650-22

Reference22 articles.

1. In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae

2. Tetraphase Pharmaceuticals. 2018. XERAVA (eravacycline) for injection, for intravenous use package insert. Tetraphase Pharmaceuticals, La Jolla, CA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211109lbl.pdf.

3. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline

4. Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City

5. In vitro activity of eravacycline and mechanisms of resistance in enterococci

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates;Frontiers in Microbiology;2024-03-27